| Literature DB >> 33594834 |
Helena Fransson1,2, Thomas Davidson3, Madeleine Rohlin4, Helena Christell5.
Abstract
OBJECTIVES: Direct cost for methods of prediction also named risk assessment in dentistry may be negligible compared with the cost of extensive constructions. On the other hand, as risk assessment is performed daily and for several patients in general dental practice, the costs may be considerable. The objective was to summarize evidence in studies of economic evaluation of prognostic prediction multivariable models and methods of caries and periodontitis and to identify knowledge gaps (PROSPERO registration number: CRD42020149763).Entities:
Keywords: cost effectiveness; economics; risk assessment; systematic review
Mesh:
Year: 2021 PMID: 33594834 PMCID: PMC8204028 DOI: 10.1002/cre2.405
Source DB: PubMed Journal: Clin Exp Dent Res ISSN: 2057-4347
Tool for critical appraisal of studies of economic evaluation of prognostic multivariable methods and models for prediction of caries and periodontitis
| First author | ||||||
|---|---|---|---|---|---|---|
| Journal/year/volume/pages | Evaluated by | Date | Yes | No | Unclear | NA |
|
| ||||||
| Was target population to whom prediction method/model applies described? | ||||||
| Was setting of recruitment described (e.g., primary care, secondary care, general population)? | ||||||
| Were number, age and sex of included individuals presented? | ||||||
| Was disease prevalence of included groups presented? | ||||||
| Was study dates presented? | ||||||
|
| ||||||
| Was method for prediction described to permit replication? | ||||||
| Was model with types and handling of predictors described to permit replication? | ||||||
| Were examination method(s) and measurements presented? | ||||||
| Was number of examiners and their experience described? | ||||||
| If implemented was thresholds clearly described? | ||||||
| Was timing of measurement of predictor(s) described? | ||||||
|
| ||||||
| Was type of outcome(s) to be predicted defined? | ||||||
| Were outcome thresholds and criteria for thresholds clearly described? | ||||||
| Were examination method(s) and measurements presented? | ||||||
| Was outcome assessed without knowledge of candidate predictors (blinded assessment)? | ||||||
| Was performance of model or method presented adequately? | ||||||
|
| ||||||
| Was the study design appropriate? | ||||||
| If simulation was used was the model transparent? | ||||||
| Was the perspective of the evaluation presented? | ||||||
| Were all relevant costs identified, presented and valued? | ||||||
| Was time horizon long enough to reflect all relevant costs and effects? | ||||||
| Were outcome measures captured and quantified for all important effects? | ||||||
| Was discount rate(s) stated? | ||||||
| Was uncertainty considered? | ||||||
|
| ||||||
| Was the result presented as costs related to effects (ratio)? | ||||||
| Was sensitivity analysis with relevant variables performed? | ||||||
| Is the result robust in regard to results of sensitivity analysis? | ||||||
| Is the result transferable to other settings? | ||||||
| Is the analysis helpful for a decision‐maker? | ||||||
|
| ||||||
| Not applicable | ||||||
FIGURE 1Flow diagram according to PRISMA Statement (Shemilt et al., 2019) presenting results of searches performed on September 4, 2019 and up‐dated September 2, 2020 and study selection
Characteristics of included studies on economic evaluation of prognostic prediction methods and multivariable models of caries or periodontitis
| Reference | Sample | Prognostic prediction method and model | Economic evaluation | Results by authors | |||
|---|---|---|---|---|---|---|---|
|
Number ( Age (year) Setting |
Method/model Follow‐up time | Predictive performance | Study design | Type of evaluation: stated by authors as defined by Husereau et al. ( | Costs presented as | ||
|
| |||||||
| Jokela and Pienihäkkinen ( |
Group I Risk‐based prevention
Group II Routine prevention
2 years One group in each of two municipal health centers (1989–1993) |
Group I: risk‐based prevention based on dental assistants' screening of low risk: MS‐free and caries‐free intermediate risk: MS‐positive with no caries high risk: signs of caries Group II: routine prevention based on dentists' decisions. Follow‐up time 3 years |
Performance
low‐risk versus intermediate + high‐risk 0.72 low‐risk + intermediate versus high‐risk 0.32
low‐risk versus intermediate + high‐risk 0.77 low‐risk + intermediate versus high‐risk 0.98 | Empirical study |
Cost analysis Cost analysis | Mean running costs in Euros (€) |
Cost per child for 3‐year time for examination, prevention and treatment: Group I 54€ Group II 69€ (Student's Risk‐based prevention can be effective in reducing both costs and dental caries in preschool children when screening and preventive measures are delegated to dental assistants |
| Zavras et al. ( |
1 or 2 years Community‐based private pediatric dental practice (1988–1995) |
Group I: microbiological screening of salivary MS recorded as colony‐forming units (CFU) counts Group II: no screening Follow‐up time 1 or 2 years NR |
Predictive performance based on CFU levels (low, moderate, high, too numerous to count) to predict caries:
at 1 year 0.37–0.66 at 2 years 0.34–0.72
at 1 year 0.96–0.88 at 2 years 0.96–0.81 | Model study |
Cost analysis Cost analysis |
Cost in US$ Costs based on fees for New England dental insurers |
Cost for predictive method 20$ Total cost per child Group I 367.90$ Group II 396.70$ Cumulative dental treatment cost for a child aged 4 years lower if the child was screened Caries prevalence 15% (range 5%–51%) Cost savings increase significantly when caries prevalence increases |
|
| |||||||
| Holst and Braune ( |
2–4 years One test clinic in public dental health (1987–1991) versus. all public dental health clinics in one county (1991) |
Risk assessment in test clinic based on factors given different weights: health status, medication, eating and drinking habits, oral hygiene, use of fluorides, parents knowledge of caries, parents interest in given information, visible caries Follow‐up times: from 2 to 4 years from 3 to 4 years Risk‐assessment by dental assistants and follow‐up examination by dentist |
Predictive performance of risk assessment for manifest caries lesion:
at 2–4 years 0.42 at 3–4 years 0.58
at 2–4 years 1.0 at 3–4 years 0.99 | Empirical study |
NR Cost‐effectiveness analysis | Mean time (min) spent per child up to 4 years at test clinic compared with mean time per child at clinics of the whole county based on county epidemiology |
Mean value for time spent (min) at: test clinic 27 for dentist and 71 for dental assistant county clinics 60 for dentists and 90 for dental assistants Time spent was 50 min less in test clinic Caries prevalence 19% at test clinic and 23% at county clinics Test model for caries prevention is cost‐effective |
| Holst et al. ( |
2–4 years
3–4 years One test clinic in public dental health (1990–1994) versus all public dental health clinics in one county (1994) |
Risk assessment based on any single factor: illness for 1 week more than four times a year, saliva inhibiting drug, six daily intakes of food/drinks, anything else but water at night, oral hygiene less than once a day, no fluorides, visible plaque, visible caries Follow‐up times: from 2 to 4 years from 3 to 4 years Risk assessment by a dental assistant and follow‐up examination by dentist |
Predictive accuracy of risk assessment for manifest caries lesions:
at age 2–4 years 1.0 at age 3–4 years 0.86
at age 2–4 years 0.70 at age 3–4 years 0.66 | Empirical study |
NR Cost‐effectiveness analysis | Mean time minutes (min) spent per child up to 4 years at test clinic compared with mean time per child at county clinics based on county epidemiology |
Mean value ‐time spent (min) at: test clinic 14 for dentist and 152 for dental assistant county clinics 42 for dentist and 102 for dental assistant Time spent for dentist was 28 min less in test clinic Caries prevalence 7% at test clinic and 24% at county clinics Test model for caries prevention is cost‐effective |
|
| |||||||
| Higashi et al. ( |
Hypothetical cohort with patients 35 years with mild periodontitis representing eight sub cohorts based on: treatment/no treatment smoker/non‐smoker Interleukin‐1 (IL‐1) genotype positive/negative Setting: periodontist specialist clinic |
IL‐1 test (positive or negative) Follow‐up time: 30 years Periodontist | Predictive accuracy used for modeling assumption to identify patients with high risk for progression to severe periodontal disease: PPV 0.97 (range 0.94–1) NPV 0.97 (range 0.94–1) | Model study based on decision‐analysis and Markov modeling |
Cost‐effectiveness analysis Cost‐utility analysis | Cost in US$ per Quality‐Adjusted Life‐Year (QALY) |
Calculations of cost for genetic test 218$ Use of test compared with no‐test resulted in additional cost of 147,114$ per 1000 patients over a 30‐year time frame Reduction of number of cases with severe periodontitis 6.1 (absolute decrease 0.61%) QALYs increased by 4.5 using test Genetic test compared to no‐test ICER 32,633$ per QALY gained |
| Martin et al. ( |
Group I patients receiving periodontal treatment
mean age 46 years (range 19–84) (1971–2003) Group II patients receiving routine dental care
mean age 47.3 years (range 28–71) (1968–1988) Setting: private dental clinics |
Chronic periodontitis (CP) risk score based on following factors: patient age, periodontal disease severity (deepest pocket, bleeding on probing, greatest radiographic bone loss), smoking history, diabetic status, periodontal treatment history, furcation involvements, vertical bone lesions, subgingival calculus or restorations Risk on a scale of 1 (very low risk) to 5 (very high risk) for alveolar bone loss and tooth loss Follow‐up: 13 years NR |
Prediction of tooth loss Score 2 versus 3, 4, 5:
PPV 0.59 NPV 0.80 LR+ 1.4 LR− 0.25 Score 2, 3 versus 4, 5:
PPV 0.71 NPV 0.64 LR+ 2.7 LR− 0.51 Score 2, 3, 4 versus 5:
PPV 0.83 NPV 0.56 LR+ 4.8 LR− 0.72 | Model study |
Cost–benefit analysis Cost‐effectiveness | Cost in US$ of periodontal treatment to preserve one tooth related to risk score and severity of CP |
For high or moderate risk combined with any severity of CP, cost of periodontal treatment divided by number of teeth preserved ranged from 1405 to 4895$ Periodontal treatment is justified on basis of tooth preservation when risk is moderate or high regardless of CP severity For low risk with mild CP, cost of periodontal treatment is higher than fixed replacement |
Abbreviations: ICER, incremental cost‐effectiveness ratio; LR, likelihood ratio; NPV, negative predictive value; NR, not reported; PPV, positive predictive value.
In detail in Pienihäkkinen and Jokela (2002).
Similar model as in study above. Different factors and extended sample.
According to our calculations based on Fig. 4 in Page et al. (2003).
Critical appraisal of included studies on economic evaluation of prognostic prediction methods and multivariable models of caries or periodontitis
| Strengths | Weaknesses | |||||
|---|---|---|---|---|---|---|
| Reference | Prediction method/model and Outcome to be predicted | Economic evaluation | Analysis and interpretation of results | Prediction method/model and Outcome to be predicted | Economic evaluation | Analysis and interpretation of results |
| Jokela and Pienihäkkinen ( |
|
Cost‐analysis with cost for labor and material Perspective of health care provider stated Year value of money 1993 Sensitivity analysis performed for risk groups | – |
|
No data on cost for prediction model, which will add to costs No discounting of costs |
No presentation of costs related to effects As description of prediction method is limited it is questionable whether analysis is helpful for a decision‐maker |
| Zavras et al. ( |
|
Perspective of private dental practitioner stated Discounting at different rates | Sensitivity analysis showed robust result |
Performance overestimated, based on high caries prevalence and on a study impossible to retrieve |
Method not described to permit replication Costs based on fees with no reference Year value of money not presented |
Results are not transferable to a setting with low caries prevalence As description of method for prediction is limited it is questionable whether analysis is helpful for a decision‐maker |
| Holst and Braune ( |
| – | Resource use estimated in minutes which may have higher generalizability than monetary cost |
|
No estimation of monetary cost Type of evaluation not stated Perspective not stated | No sensitivity analysis performed |
| Holst et al. ( |
| – | Resource use estimated in minutes which may have higher generalizability than monetary cost |
|
No estimation of monetary cost Type of evaluation not stated Perspective not stated | No sensitivity analysis performed |
| Higashi et al. ( |
|
Markov model Cost for genetic test and laboratory fee presented Discounting at different rates Perspective of health care payer stated |
Cost per QALY presented Sensitivity analysis performed Transferable to a general population around 35 years Helpful for a decision‐maker |
|
Cost for interleukin genetics modeled with no reference Year value of money not presented | Not robust in regard to results of sensitivity analysis |
| Martin et al. ( |
Relevant long‐term follow‐up |
Economic model described with reference Year value of money 2011 |
|
Data on cost per tooth only for periodontal and prosthodontic treatment No data on cost for prediction model which will add to costs No perspective stated No discounting of data |
No sensitivity analysis performed Results not transferable to a setting of men and women As description of method for prediction is limited it is questionable whether analysis is helpful for a decision‐maker | |
Note: Studies assessed using tool presented in Table 1 and results of appraisal summarized as strengths and weaknesses.